Share on StockTwits

Cyprotex plc (LON:CRX)‘s stock had its “corporate” rating reissued by analysts at N+1 Singer in a research report issued to clients and investors on Thursday.

Cyprotex plc (LON:CRX) traded down 3.85% on Thursday, hitting GBX 50.00. 46,401 shares of the company’s stock traded hands. Cyprotex plc has a 1-year low of GBX 50.00 and a 1-year high of GBX 82.50. The stock has a 50-day moving average of GBX 6.9 and a 200-day moving average of GBX 6.85.

Cyprotex PLC (LON:CRX) is a holding company specializing in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.